From embryonic stem cells to iPS - an ethical perspective.
作者信息
Suaudeau J
机构信息
Pontifical Academy for Life, Rome, Italy.
出版信息
Cell Prolif. 2011 Apr;44 Suppl 1(Suppl 1):70-84. doi: 10.1111/j.1365-2184.2010.00723.x.
Abstract
摘要
相似文献
1
From embryonic stem cells to iPS - an ethical perspective.从胚胎干细胞到诱导多能干细胞——伦理视角
Cell Prolif. 2011 Apr;44 Suppl 1(Suppl 1):70-84. doi: 10.1111/j.1365-2184.2010.00723.x.
2
The ethics of stem cells revisited.重新审视干细胞的伦理问题。
Adv Drug Deliv Rev. 2015 Mar;82-83:176-80. doi: 10.1016/j.addr.2014.11.011. Epub 2014 Nov 14.
3
Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects.我们是否仍需要人类胚胎干细胞进行基于干细胞的治疗？认识论和伦理方面。
Stem Cell Rev Rep. 2011 Nov;7(4):761-74. doi: 10.1007/s12015-011-9257-3.
4
[Ethical reflections on cell reprogramming].[关于细胞重编程的伦理思考]
Cuad Bioet. 2012 May-Aug;23(78):287-99.
5
Ethical considerations in chimera research.嵌合体研究中的伦理考量。
Development. 2015 Jan 1;142(1):3-5. doi: 10.1242/dev.119024.
6
How to depolarise the ethical debate over human embryonic stem cell research (and other ethical debates too!).如何消除人类胚胎干细胞研究（以及其他伦理辩论）的伦理辩论中的极化现象！
J Med Ethics. 2012 Aug;38(8):496-500. doi: 10.1136/medethics-2011-100099. Epub 2012 Feb 28.
7
No ethical bypass of moral status in stem cell research.在干细胞研究中，没有道德绕过道德地位。
Bioethics. 2013 Jan;27(1):12-9. doi: 10.1111/j.1467-8519.2011.01891.x. Epub 2011 Jul 4.
8
An ethical framework for expanded access to cell-based therapies.扩大细胞疗法可及性的伦理框架。
Regen Med. 2011 May;6(3):273-5. doi: 10.2217/rme.11.12.
9
Advances in cell lineage reprogramming.细胞谱系重编程的进展。
Sci China Life Sci. 2013 Mar;56(3):228-33. doi: 10.1007/s11427-013-4447-7. Epub 2013 Mar 23.
10
Alternative sources of pluripotent stem cells: ethical and scientific issues revisited.替代性多能干细胞来源：伦理和科学问题再探讨。
Stem Cells Dev. 2010 Aug;19(8):1121-9. doi: 10.1089/scd.2009.0482.
引用本文的文献
1
Mitochondrial genome mutations and neuronal dysfunction of induced pluripotent stem cells derived from patients with Alzheimer's disease.阿尔茨海默病患者诱导多能干细胞的线粒体基因组突变和神经元功能障碍。
Cell Prolif. 2022 Jul;55(7):e13274. doi: 10.1111/cpr.13274. Epub 2022 Jun 13.
2
Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.诱导多能干细胞研究的标本采集：协调知情同意书的方法。
Stem Cells Transl Med. 2012 May;1(5):409-21. doi: 10.5966/sctm.2012-0029. Epub 2012 May 8.
3
Impedance of novel therapeutic technologies: the case of stem cells.新型治疗技术的阻抗：以干细胞为例。
Clin Transl Sci. 2012 Oct;5(5):422-7. doi: 10.1111/j.1752-8062.2012.00434.x. Epub 2012 Jun 28.
4
Stem cells for reprogramming: could hUMSCs be a better choice?重编程用干细胞：人 UMSC 会不会是更好的选择？
Cytotechnology. 2013 May;65(3):335-45. doi: 10.1007/s10616-012-9489-3. Epub 2012 Sep 12.
5
Derivation of male germ cells from induced pluripotent stem cells in vitro and in reconstituted seminiferous tubules.体外诱导多能干细胞和重建生精小管中雄性生殖细胞的分化。
Cell Prolif. 2012 Apr;45(2):91-100. doi: 10.1111/j.1365-2184.2012.00811.x. Epub 2012 Feb 13.
本文引用的文献
1
Straight talk with...George Daley. Interview by Elie Dolgin.直话直说......乔治·戴利访谈。埃利·多尔金采访。
Nat Med. 2010 Jun;16(6):624. doi: 10.1038/nm0610-624.
2
Regulators must step up stem cell oversight.监管机构必须加强对干细胞的监管。
Nat Med. 2010 May;16(5):492. doi: 10.1038/nm0510-492.
3
Stem cells. Reprogrammed cells come up short, for now.干细胞。目前，重编程细胞仍存在不足。
Science. 2010 Mar 5;327(5970):1191. doi: 10.1126/science.327.5970.1191.
4
Human iPS cell-based therapy: considerations before clinical applications.基于人诱导多能干细胞的治疗：临床应用前的考虑因素。
Cell Cycle. 2010 Mar 1;9(5):880-5. doi: 10.4161/cc.9.5.10827. Epub 2010 Mar 2.
5
Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.人类诱导多能干细胞的神经分化遵循发育原则，但具有可变的潜能。
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4335-40. doi: 10.1073/pnas.0910012107. Epub 2010 Feb 16.
6
Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence.人诱导多能干细胞的血管母细胞衍生物表现出有限的扩增和早期衰老。
Stem Cells. 2010 Apr;28(4):704-12. doi: 10.1002/stem.321.
7
The bioethics of stem cell research and therapy.干细胞研究与治疗的生命伦理学
J Clin Invest. 2010 Jan;120(1):71-5. doi: 10.1172/JCI40435.
8
Stem cell research policy and iPS cells.干细胞研究政策与诱导多能干细胞
Nat Methods. 2010 Jan;7(1):28-33. doi: 10.1038/nmeth.f.282.
9
iPS cells: mapping the policy issues.诱导多能干细胞：政策问题剖析。
Cell. 2009 Dec 11;139(6):1032-7. doi: 10.1016/j.cell.2009.11.039.
10
Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation.人类 DAZL、DAZ 和 BOULE 基因调节原始生殖细胞和单倍体配子的形成。
Nature. 2009 Nov 12;462(7270):222-5. doi: 10.1038/nature08562. Epub 2009 Oct 28.
Zotero 插件